Chronically Ill? In Kennedy’s View, It Might Be Your Own Fault
In their zeal to “Make America Healthy Again,” top Trump administration officials depict patients and the doctors who treat them as partly responsible for whatever ails them.
Drugs
61 - 80 of 1,300 Results
-
Here Come the ACA Premium Hikes
Episode 407Medicaid may have monopolized Washington’s attention lately, but big changes are coming to the Affordable Care Act as well. Meanwhile, Americans are learning more about what’s in Trump’s big budget law, and polls suggest many don’t like what they see. Julie Appleby of Ńîąóĺú´«Ă˝Ň•îl Health News, Jessie Hellmann of CQ Roll Call, and Alice Miranda Ollstein of Politico join Ńîąóĺú´«Ă˝Ň•îl Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews historian Jonathan Oberlander to mark Medicare’s 60th anniversary.
The Senate Saves PEPFAR Funding — For Now
Episode 406The Senate narrowly approved the Trump administration’s request to claw back about $9 billion for foreign aid and public broadcasting but refused to cut funding for the international AIDS/HIV program PEPFAR. Meanwhile, a federal appeals court ruled that West Virginia can ban the abortion pill mifepristone, which could allow states to block other FDA-approved drugs. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join Ńîąóĺú´«Ă˝Ň•îl Health News’ Julie Rovner to discuss these stories and more.
-
Maybe It’s Not Just Aging. Maybe It’s Anemia.
Significant numbers of older people have the condition. Many find relief with an effective treatment that is being more widely prescribed.
By Paula Span The Prescription Drug Playbook, Part II
Season 13, Episode 10In this second part of a two-part series on dealing with the high price of prescription drugs, experts share their insider tips.
-
Journalists Assess Health Impacts of Trump’s Megabill, Who Will Feel Them, and When
Ńîąóĺú´«Ă˝Ň•îl Health News journalists made the rounds on national and regional media this week to discuss topical stories. Here’s a collection of their appearances.
-
Journalists Break Down Reconciliation Bill, Vaccine Panel Meeting, and ‘Dobbs’ Anniversary
Ńîąóĺú´«Ă˝Ň•îl Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a collection of their appearances.
Supreme Court Upholds Bans on Gender-Affirming Care
Episode 402The Supreme Court this week said Tennessee may continue to enforce its law banning most types of gender-affirming care for minors. The ruling is likely to greenlight similar laws in two dozen states. And the Senate is preparing to vote on a budget reconciliation bill that includes even deeper Medicaid cuts than the House version. Victoria Knight of Axios, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join Ńîąóĺú´«Ă˝Ň•îl Health News’ Julie Rovner to discuss these stories and more.
The Prescription Drug Playbook, Part I
Season 13, Episode 9In Part 1 of a two-part series on dealing with the high price of prescription drugs, a father explains the strategies he used to get his daughter the medicine she needs to treat her epilepsy.
-
A Revolutionary Drug for Extreme Hunger Offers Clues to Obesity’s Complexity
A new drug is helping families who’ve spent years padlocking fridges, chaining garbage cans, and hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger. But additional progress — and a broader understanding of obesity — is now under threat as the government dismantles the pipeline for promising new research.
-
In Axing mRNA Contract, Trump Delivers Another Blow to US Biosecurity, Former Officials Say
The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health budgets, and withdraws funding for bird flu vaccines, health security experts said.
By Amy Maxmen -
Two Patients Faced Chemo. The One Who Survived Demanded a Test To See if It Was Safe.
Worried that President Donald Trump’s FDA might not act, a panel of cancer experts recommended that doctors consider testing before dosing patients with a commonly used but sometimes deadly cancer drug. It came too late for many patients.
By Arthur Allen -
Trump Won’t Force Medicaid To Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
Late last year, South Carolina Medicaid approved a class of medications known as GLP-1s to treat obesity, placing it among the few state programs covering these effective but expensive drugs. But access remains limited, even for patients covered by Medicaid, because of stringent prerequisites that must be satisfied before starting the drug.
-
Trump Exaggerates Speed and Certainty of Prescription Drug Price Reductions
According to the timeline in the May 12 executive order, prescription drug price reductions would not happen "almost immediately,” but rather could take months or years. And extending the savings to Americans outside federal health insurance programs such as Medicare would likely require congressional action.
-
How Trump Aims To Slash Federal Support for Research, Public Health, and MedicaidÂ
One thing experts agree on: The damage from the funding cuts will be varied and immense.
-
Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs
While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account for 90% of U.S. prescriptions — see trouble ahead for patients.
By Jackie Fortiér and Arthur Allen GOP Tries To Cut Billions in Health Benefits
Episode 397GOP-controlled House committees approved parts of President Donald Trump’s “one big, beautiful bill” this week, including more than $700 billion in cuts to health programs over the next decade — mostly from Medicaid, which covers people with low incomes or disabilities. Meanwhile, Health and Human Services Secretary Robert F. Kennedy Jr. testified before Congress for the first time since taking office and told lawmakers that Americans shouldn’t take medical advice from him. Julie Appleby of Ńîąóĺú´«Ă˝Ň•îl Health News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine join Ńîąóĺú´«Ă˝Ň•îl Health News’ Julie Rovner to discuss these stories and more.
-
Pain Clinic CEO Faced 20 Years for Making Patients ‘Human Pin Cushions.’ He Got 18 Months.
Michael Kestner, CEO of Pain MD, was convicted of 13 fraud felonies after his company gave patients hundreds of thousands of questionable injections at clinics in Tennessee, Virginia, and North Carolina.
By Brett Kelman -
Honey, Sweetie, Dearie: The Perils of Elderspeak
A new training program teaches workers to stop the baby talk and address older people as adults.
By Paula Span Cutting Medicaid Is Hard — Even for the GOP
Episode 396Republicans on Capitol Hill are struggling to reach consensus on cutting the Medicaid program as they search for nearly a trillion dollars in savings over the next decade — as many observers predicted. Meanwhile, turmoil continues at the Department of Health and Human Services, with more controversial cuts and personnel moves, including the sudden nomination of Casey Means, an ally of Robert F. Kennedy Jr.’s, to become surgeon general. Anna Edney of Bloomberg News, Maya Goldman of Axios, and Sandhya Raman of CQ Roll Call join Ńîąóĺú´«Ă˝Ň•îl Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Ńîąóĺú´«Ă˝Ň•îl Health News’ Lauren Sausser, who co-reported the latest “Bill of the Month” feature, about an unexpected bill for what seemed like preventive care.